Company Filing History:
Years Active: 2016-2020
Title: David Fry: Innovator in Pharmaceutical Chemistry
Introduction
David Fry is a notable inventor based in Boulder, CO (US), recognized for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on innovative compounds and their therapeutic applications. His work is instrumental in advancing treatments for diseases associated with RET kinase inhibition.
Latest Patents
Fry's latest patents include novel crystalline forms of compounds that exhibit RET kinase inhibition. These compounds, identified as Formula I-IV, are designed to treat and prevent diseases related to RET-associated disorders. Additionally, he has developed a solid dispersion of a HER2 inhibitor, which includes processes for preparing the solid dispersion and its pharmaceutical applications.
Career Highlights
David Fry is currently associated with Array Biopharma Inc., where he continues to push the boundaries of pharmaceutical innovation. His research focuses on creating effective therapeutic solutions that address critical health challenges.
Collaborations
Fry collaborates with esteemed colleagues, including Christopher M. Lindemann and Michael Preigh, to enhance the impact of his research and development efforts.
Conclusion
David Fry's innovative work in pharmaceutical chemistry exemplifies the importance of research and collaboration in developing effective treatments. His contributions significantly advance the field and hold promise for future medical breakthroughs.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.